Advanced Inhalation Therapies Gets Orphan Drug Status for Treatment of Cystic Fibrosis

Israel’s Advanced Inhalation Therapies Ltd (AIT), a company which develops therapies that utilize the gas Nitric Oxide, announced that the U.S. Food and Drug Administration granted Orphan Drug Designation More...